피리도[3,4-d]피리미딘 유도체 및 그 약학적으로 허용되는 염
본 발명의 목적은, 우수한 CDK4/6 저해 활성을 갖는 화합물을 제공하는 것이다. 본 발명은, 식 (I) 로 나타내는 화합물 또는 그 약학적으로 허용되는 염이다. The purpose of the present invention is to provide a compound that has excellent CDK4/6 inhibitory activity. The present invention is a compound represented by formula (I) or a pharmaceutically acceptable sal...
Saved in:
| Main Authors | , , , , , , , , |
|---|---|
| Format | Patent |
| Language | Korean |
| Published |
13.06.2019
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | 본 발명의 목적은, 우수한 CDK4/6 저해 활성을 갖는 화합물을 제공하는 것이다. 본 발명은, 식 (I) 로 나타내는 화합물 또는 그 약학적으로 허용되는 염이다.
The purpose of the present invention is to provide a compound that has excellent CDK4/6 inhibitory activity. The present invention is a compound represented by formula (I) or a pharmaceutically acceptable salt of the compound. |
|---|---|
| AbstractList | 본 발명의 목적은, 우수한 CDK4/6 저해 활성을 갖는 화합물을 제공하는 것이다. 본 발명은, 식 (I) 로 나타내는 화합물 또는 그 약학적으로 허용되는 염이다.
The purpose of the present invention is to provide a compound that has excellent CDK4/6 inhibitory activity. The present invention is a compound represented by formula (I) or a pharmaceutically acceptable salt of the compound. |
| Author | SASAKI KOSUKE SHIMADA TOMOHIRO UNOKI GEN SAKAI YURI HORIE KYOHEI YOKOSAKA TAKUYA MARUYAMA AKINOBU TAKAHASHI HIROSHI MIZUNO TSUYOSHI |
| Author_xml | – fullname: SHIMADA TOMOHIRO – fullname: TAKAHASHI HIROSHI – fullname: SAKAI YURI – fullname: MIZUNO TSUYOSHI – fullname: UNOKI GEN – fullname: YOKOSAKA TAKUYA – fullname: SASAKI KOSUKE – fullname: MARUYAMA AKINOBU – fullname: HORIE KYOHEI |
| BookMark | eNrjYmDJy89L5WTwfztlz-tla173t0Qb65jopsRC-et3vJ4yQ-HNnAVAmTebtii83tCv8Gr7DoU3U_e-nTrzzYLGN3P2vF44R-Ht9I43s1a-njDjddcUhTfT9_AwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUknjvICMDQ0sDAzMzM2NDR2PiVAEA59BOLg |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | KR20190066631A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_KR20190066631A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:19:24 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | Korean |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_KR20190066631A3 |
| Notes | Application Number: KR20197014607 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190613&DB=EPODOC&CC=KR&NR=20190066631A |
| ParticipantIDs | epo_espacenet_KR20190066631A |
| PublicationCentury | 2000 |
| PublicationDate | 20190613 |
| PublicationDateYYYYMMDD | 2019-06-13 |
| PublicationDate_xml | – month: 06 year: 2019 text: 20190613 day: 13 |
| PublicationDecade | 2010 |
| PublicationYear | 2019 |
| RelatedCompanies | TEIJIN PHARMA LIMITED |
| RelatedCompanies_xml | – name: TEIJIN PHARMA LIMITED |
| Score | 3.1819384 |
| Snippet | 본 발명의 목적은, 우수한 CDK4/6 저해 활성을 갖는 화합물을 제공하는 것이다. 본 발명은, 식 (I) 로 나타내는 화합물 또는 그 약학적으로 허용되는 염이다.
The purpose of the present invention is to provide a compound that... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | 피리도[3,4-d]피리미딘 유도체 및 그 약학적으로 허용되는 염 |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190613&DB=EPODOC&locale=&CC=KR&NR=20190066631A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTMBtlFTLFN0zVNSjXRNjJLNdRNNUpJ1k5KNzFLNEs2MEw1AG4V9_cw8Qk28IkwjmBhyYHthwOeEloMPRwTmqGRgfi8Bl9cFiEEsF_DaymL9pEygUL69W4itixq0dwys3YDVk5qLk61rgL-Lv7Oas7Otd5CaXxBEDtRWNzZ0ZGZgBTWkQSftu4Y5gfalFCBXKm6CDGwBQPPySoQYmLLzhRk4nWF3rwkzcPhCp7yBTGjuKxZh8H87Zc_rZWte97dEG-uY6KbEQvnrd7yeMkPhzZwFQJk3m7YovN7Qr_Bq-w6FN1P3vp06882Cxjdz9rxeOEfh7fSON7NWvp4w43XXFIU30_eIMii7uYY4e-gCXRYPD4h47yBkbxiLMbDk5eelSjAomKVZmhibmSSbpAHbEynGiUnJlikmSWapKUAIrKITJRlk8JkkhV9amoELxAUtkDI0lmFgKSkqTZUFVsUlSXLgEAQAkcKjRQ |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTMBtlFTLFN0zVNSjXRNjJLNdRNNUpJ1k5KNzFLNEs2MEw1AG4V9_cw8Qk28IkwjmBhyYHthwOeEloMPRwTmqGRgfi8Bl9cFiEEsF_DaymL9pEygUL69W4itixq0dwys3YDVk5qLk61rgL-Lv7Oas7Otd5CaXxBEDtRWNzZ0ZGZgNQedzwtqPIU5gfalFCBXKm6CDGwBQPPySoQYmLLzhRk4nWF3rwkzcPhCp7yBTGjuKxZh8H87Zc_rZWte97dEG-uY6KbEQvnrd7yeMkPhzZwFQJk3m7YovN7Qr_Bq-w6FN1P3vp06882Cxjdz9rxeOEfh7fSON7NWvp4w43XXFIU30_eIMii7uYY4e-gCXRYPD4h47yBkbxiLMbDk5eelSjAomKVZmhibmSSbpAHbEynGiUnJlikmSWapKUAIrKITJRlk8JkkhV9anoHTI8TXJ97H089bmoELJAVaLGVoLMPAUlJUmioLrJZLkuTAoQkAXgmmMg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%ED%94%BC%EB%A6%AC%EB%8F%84%5B3%2C4-d%5D%ED%94%BC%EB%A6%AC%EB%AF%B8%EB%94%98+%EC%9C%A0%EB%8F%84%EC%B2%B4+%EB%B0%8F+%EA%B7%B8+%EC%95%BD%ED%95%99%EC%A0%81%EC%9C%BC%EB%A1%9C+%ED%97%88%EC%9A%A9%EB%90%98%EB%8A%94+%EC%97%BC&rft.inventor=SHIMADA+TOMOHIRO&rft.inventor=TAKAHASHI+HIROSHI&rft.inventor=SAKAI+YURI&rft.inventor=MIZUNO+TSUYOSHI&rft.inventor=UNOKI+GEN&rft.inventor=YOKOSAKA+TAKUYA&rft.inventor=SASAKI+KOSUKE&rft.inventor=MARUYAMA+AKINOBU&rft.inventor=HORIE+KYOHEI&rft.date=2019-06-13&rft.externalDBID=A&rft.externalDocID=KR20190066631A |